Skip to main content
Log in

Involvement of tachykinin receptors in oedema formation and plasma extravasation induced by substance P, neurokinin A, and neurokinin B in mouse ear

  • Original Research Papers
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

The involvement of tachykinin receptors in skin inflammation induced by substance P (SP), neurokinin A (NKA), and neurokinin B (NKB) was investigated in mouse ears. Intradermal injection of tachykinins (0.1–100 pmol/site) into the ear skin produced oedema formation. RP 67580 (ED50:0.34 mg/kg, i.v.) and SR 140333 (ED50:0.19 mg/kg, i.v.), the non-peptide NK1 receptor antagonists, inhibited SP-induced oedema. SR 140333 was also effective in preventing NKA- and NKB-induced oedema. SR 48968 (1 mg/kg, i.v.), a non-peptide NK2 antagonist, induced a significant inhibition of NKA-induced oedema but had no effect on the response to SP and NKB. SR 142801 (3 mg/kg, i.v.), a non-peptide NK3 antagonist, prevented only NKB-induced oedema. In contrast, phosphoramidon (0.1 and 0.5 mg/kg, i.v.), an endopeptidase inhibitor, enhanced the oedema response to tachykinins. SR 140333, SR 48968, and SR 142801 blocked the enhancement by phosphoramidon of the response to SP, NKA, and NKB, respectively. Plasma extravasation in ear skin was induced by i.v. injection of tachykinins (0.7–17.6 nmol/kg). RP 67580 (ED50:0.15 mg/kg, i.v. for SP) and SR 140333 (ED50:14.3 μg/kg, i.v. for SP) inhibited tachykinin-induced plasma extravasation in ear skin. However, SR 48968 and SR 140281 had no effect on the vascular response to tachykinins. Chlorpheniramine (4 mg/kg, i.v.), a histamine H1 blocker, inhibited the response to local SP but not to i.v. SP. These results suggest that in addition to the NK1 receptors, functional NK2 and NK3 receptors may participate in the oedema response to local NKA and NKB in the ear skin. However, it appears that NK1 receptors on blood vessels are involved predominantly in plasma extravasation induced by i.v. tachykinins in the ear.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988;24:739–68.

    Google Scholar 

  2. Gamse R, Saria A. Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide. Eur J Pharmacol 1985;114:61–6.

    Google Scholar 

  3. Fuller RW, Conradson T-B, Dixon CMS, Crossman DC, Barnes PJ. Sensory neuropeptide effects in human skin. Br J Pharmacol 1987;92:781–8.

    Google Scholar 

  4. Guard S, Watson SP. Tachykinin receptor types: classification and membrane signaling mechanisms. Neurochem Int 1991;18:149–65.

    Google Scholar 

  5. Andrews PV, Helme RD, Thomas KL. NK-1 receptor mediation of neurogenic plasma extravasation in rat skin. Br J Pharmacol 1989;97:1232–8.

    Google Scholar 

  6. O'Flynn NM, Helme RD, Watkins DJ, Burcher E. Autoradiographic localization of substance P binding sites in rat footpad skin. Neurosci Lett 1989;106:43–8.

    Google Scholar 

  7. Erjavec F, Lembeck F, Florjanc-Irman T, Skofitsch G, Donnerer J, Saria A, et al. Release of histamine by substance P. Naunyn-Schmiedeberg's Arch Pharmacol 1981;317:67–70.

    Google Scholar 

  8. Fewtrell CMS, Foreman JC, Jordan CC, Oehme P, Renner H, Stewart JM. The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol 1982;330:393–411.

    Google Scholar 

  9. Walsh DT, Weg VB, Williams TJ, Nourshargh S. Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators. Br J Pharmacol 1995;114:1343–50.

    Google Scholar 

  10. Lembeck F, Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch Pharmacol 1979;310:175–83.

    Google Scholar 

  11. Foreman JC, Jordan CC, Oehme P, Renner H. Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiol 1983;335:449–65.

    Google Scholar 

  12. Iwamoto I, Yamazaki H, Tomioka H, Yoshida S. Inhibitory effect of tranilast on substance P-induced plasma extravasation in rat skin. Immunopharmacol Immunotoxicol 1991;13:65–71.

    Google Scholar 

  13. Inoue H, Nagata N, Koshihara Y. Profile of capsaicin-induced mouse ear oedema as neurogenic inflammatory model: comparison with arachidonic acid-induced ear oedema. Br J Pharmacol 1993;110:1614–20.

    Google Scholar 

  14. Jacques L, Couture R, Drapeau G, Regoli D. Capillary permeability induced by intravenous neurokinins. Receptor characterization and mechanism of action. Naunyn-Schmiedeberg's Arch Pharmacol 1989;340:170–9.

    Google Scholar 

  15. Garret C, Carruette A, Fardin V, Moussaoui S, Peyronel J-F, Blanchard J-C, Laduron PM. Pharacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci USA 1991;88:10208–12.

    Google Scholar 

  16. Lembeck R, Donnerer J, Tsuchiya M, Nagahisa A. The nonpeptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation. Br J Pharmacol 1992;105:527–30.

    Google Scholar 

  17. Emonds-Alt X, Doutremepuich J-D, Heaulme M, Neliat G, Santucci V, Steinberg R, et al. In vitro and in vivo biological activities of SR 140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur J Pharmacol 1993;250:403–13.

    Google Scholar 

  18. Emonds-Alt X, Vilain P, Goulaouic P, Proietto V, Van Broeck D, Advenier C, et al. A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. Life Sci 1992;50:101–6.

    Google Scholar 

  19. Emonds-Alt X, Bichon D, Ducoux J-P, Heaulme M, Miloux B, Poncelet M, et al. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sci 1995;56:27–32.

    Google Scholar 

  20. Cochran WG, Cox GM, editors. Experimental Designs. 2nd ed. New York: Wiley, 1957.

    Google Scholar 

  21. Moussaoui SM, Montier F, Carruette A, Blanchard JC, Laduron PM, Garret C. A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically. Br J Pharmacol 1993;109:159–64.

    Google Scholar 

  22. Tousignant C, Chan C-C, Guevremont D, Brideau C, Hale JJ, MacCoss M, et al. NK2 receptors mediate plasma extravasation in guinea-pig lower airways. Br J Pharmacol 1993;108:383–6.

    Google Scholar 

  23. Maggi CA, Patacchini R, Giuliani S, Giachetti A. In vivo and in vitro pharmacology of SR 48,968, a non-peptide tachykinin NK2 receptor antagonist. Eur J Pharmacol 1993;234:83–90.

    Google Scholar 

  24. Iwamoto I, Nadel JA. Tachykinin receptor subtype that mediates the increase in vascular permeability in guinea pig skin. Life Sci 1989;44:1089–95.

    Google Scholar 

  25. Ralevic V, Khalil Z, Helme RD, Dusting GJ. Role of nitric oxide in the actions of substance P and other mediators of inflammation in rat skin microvasculature. Eur J Pharmacol 1995;284:231–9.

    Google Scholar 

  26. Gao Z-P, Robbins RA, Snider RM, Lowe III J, Rennard SI, Anding P, Rubinstein I. NK1 receptors mediate tachykinin-induced increase in microvascular clearance in hamster cheek pouch. Am J Physiol 1993;265:H593–8.

    Google Scholar 

  27. Lam FY, Ferrell WR. Specific neurokinin receptors mediate plasma extravasation in the rat knee joint. Br J Pharmacol 1991;103:1263–7.

    Google Scholar 

  28. Hirayama Y, Yasumitsu R, Kawamura A, Fujii T. NK1 receptors mediate tachykinin-induced plasma extravasation in the rat knee joint. Agents Actions 1993;40:171–5.

    Google Scholar 

  29. Matsas R, Kenny AJ, Turner AJ. The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24,11. Biochem J 1984;223:433–40.

    Google Scholar 

  30. Sakurada T, Tan-no K, Yamada T, Sakurada S, Kisara K. Phosphoramidon potentiates mammalian tachykinin-induced biting, licking, and scratching behaviour in mice. Pharmacol Biochem Behav 1990;37:779–83.

    Google Scholar 

  31. Brokaw JJ, White GW. Differential effects of phosphoramidon and captopril on NK1 receptor-mediated plasma extravasation in the rat trachea. Agents Actions 1994;42:34–9.

    Google Scholar 

  32. Johnson AR, Ashton J, Schulz WW, Erdös EG, Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis 1985;132:564–8.

    Google Scholar 

  33. Wang L, Sadoun E. Stephens RE, Ward PE. Metabolism of substance P and neurokinin A by human vascular endothelium and smooth muscle. Peptides 1994;15:497–503.

    Google Scholar 

  34. Suzuki H, Yoshioka K, Yanagisawa M, Urayama O, Kurihara T, Hosoki R, et al. Involvement of enzymatic degradation in the inactivation of tachykinin neurotransmitters in neonatal rat spinal cord. Br J Pharmacol 1994;113:310–6.

    Google Scholar 

  35. Tsuchida K, Shigemoto R, Yokota Y, Nakanishi S. Tissue distribution and quantitation of the mRNAs for three rat tachykinin receptors. Eur J Biochem 1990;193:751–7.

    Google Scholar 

  36. Stanisz AM, Scicchitano R, Dazin P, Bienenstock J, Payan DG. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J Immunol 1987;139:749–54.

    Google Scholar 

  37. Hartung H-P, Wolters K, Toyka KV. Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J Immunol 1986;136:3856–63.

    Google Scholar 

  38. von Restorff B, Kemeny L, Michel G, Ruzicka T. Specific binding of substance P in normal human keratinocytes [abstract]. J Invest Dermatol 1992;98:510.

    Google Scholar 

  39. Otsuka M, Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 1993;73:229–308.

    Google Scholar 

  40. Rameshwar P, Gascon P, Ganea D. Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins. J Immunol 1993;15:2484–96.

    Google Scholar 

  41. Herzberg U, Murtaugh MP, Mullet MA, Beitz AJ. Electrical stimulation of the sciatic nerve alters neuropeptide content and lymphocyte migration in the subcutaneous tissue of the rat hind paw. Neuroreport 1995;6:1773–7.

    Google Scholar 

  42. Abelli L, Somma V, Maggi CA, Regoli D, Astolfi M, Parlani M, et al. Effects of tachykinins and selective tachykinin receptor agonists on vascular permeability in the rat lower urinary tract: evidence for the involvement of NK-1 receptors. J Auton Pharmacol 1989;9:253–63.

    Google Scholar 

  43. Baluk P, Bertrand C, Geppetti P, McDonald DM, Nadel JA. NK1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am J Physiol 1995;268:L263–9.

    Google Scholar 

  44. Greeno EW, Mantyh P, Vercellotti GM, Moldow CF. Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium. J Exp Med 1993;177:1269–76.

    Google Scholar 

  45. Kenins P, Hurley JV, Bell C. The role of substance P in the axon reflex in the rat. Br J Dermatol 1984;111:551–9.

    Google Scholar 

  46. Regoli D, Drapeau G, Dion S, D'Orléans-Juste P. Pharmacological receptors for substance P and neurokinins. Life Sci 1987;40:109–17.

    Google Scholar 

  47. Mousli M, Bronner C, Bueb J-L, Tschirhart E, Gies J-P, Landry Y. Activation of rat peritoneal mast cells by substance P and mastoparan. J Pharm Exp Ther 1989;250:329–35.

    Google Scholar 

  48. Mousli M, Hugli TE, Landry Y, Bronner C. Peptidergic pathway in human skin and rat peritoneal mast cell activation. Immunopharmacol 1994;27:1–11.

    Google Scholar 

  49. Inoue H, Nagata N, Koshihara Y. Participation of serotinin in capsaicin-induced mouse ear edema. Jpn J Pharmacol 1995;69:61–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

accepted by G. Letts

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inoue, H., Nagata, N. & Koshihara, Y. Involvement of tachykinin receptors in oedema formation and plasma extravasation induced by substance P, neurokinin A, and neurokinin B in mouse ear. Inflamm Res 45, 316–323 (1996). https://doi.org/10.1007/BF02252943

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02252943

Key words

Navigation